Body fatness across the adult life course and ovarian cancer risk.
Body fatness
Case-control study
Life course epidemiology
Ovarian cancer
Journal
European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062
Informations de publication
Date de publication:
15 Oct 2024
15 Oct 2024
Historique:
received:
25
07
2024
accepted:
28
09
2024
medline:
15
10
2024
pubmed:
15
10
2024
entrez:
15
10
2024
Statut:
aheadofprint
Résumé
Excess body fatness in late adulthood has been observed to increase ovarian cancer risk, but the association is relatively weak. Body fatness can change over time, and timing may differently influence risk. We used a life course epidemiology approach to identify whether the relation between body fatness and ovarian cancer risk is best described by a critical period, accumulation or sensitive period hypothesis. In a population-based case-control study of ovarian cancer in Montreal, Canada (2011-16), data on body mass index (BMI) at each decade starting at age 20 was available. Among 363 cases and 707 controls aged ≥ 50 years, we used a Bayesian relevant life course exposure model to estimate the relative importance of BMI for three pre-specified periods across the adult life course, i.e., early childbearing years, late childbearing years, and peri/postmenopause, on ovarian cancer risk. The accumulation hypothesis best described BMI in relation to ovarian cancer overall, with an odds ratio (OR) for the lifetime effect of BMI (per 5 kg/m
Identifiants
pubmed: 39404972
doi: 10.1007/s10654-024-01161-1
pii: 10.1007/s10654-024-01161-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CIHR
ID : PJT-175307
Pays : Canada
Organisme : CIHR
ID : 491740
Pays : Canada
Organisme : Fonds de Recherche du Québec - Santé
ID : Fonds de Recherche du Québec - Santé
Informations de copyright
© 2024. Springer Nature B.V.
Références
International Agency for Research on Cancer. Absence of excess body fatness. IARC Handbooks of Cancer Prevention. 2016;16:1-646. https://publications.iarc.fr/570
Kyrgiou M, Kalliala I, Markozannes G, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ. 2017;356:j477. https://doi.org/10.1136/bmj.j477 .
doi: 10.1136/bmj.j477
pubmed: 28246088
pmcid: 5421437
Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med. 2012;9(4):e1001200. https://doi.org/10.1371/journal.pmed.1001200 .
doi: 10.1371/journal.pmed.1001200
pmcid: 3317899
World Cancer Research Fund/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. Continuous Updated Project Expert Report. 2018. https://dietandcancerreport.org
Kurnit KC, Fleming GF, Lengyel E. Updates and New options in Advanced Epithelial Ovarian Cancer Treatment. Obstet Gynecol. 2021;137(1):108–21. https://doi.org/10.1097/aog.0000000000004173 .
doi: 10.1097/aog.0000000000004173
pubmed: 33278287
Menon U, Gentry-Maharaj A, Burnell M, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2021;397(10290):2182–93. https://doi.org/10.1016/S0140-6736(21)00731-5 .
doi: 10.1016/S0140-6736(21)00731-5
pubmed: 33991479
pmcid: 8192829
Brown SB, Hankinson SE. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers. Steroids. 2015;99(Pt A):8–10. https://doi.org/10.1016/j.steroids.2014.12.013 .
doi: 10.1016/j.steroids.2014.12.013
pubmed: 25555473
Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls. Lancet. 2008;371(9609):303–14. https://doi.org/10.1016/S0140-6736(08)60167-1 .
doi: 10.1016/S0140-6736(08)60167-1
Beral V, Gaitskell K, Hermon C, Moser K, Reeves G, Peto R. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet. 2015;385(9980):1835–42. https://doi.org/10.1016/s0140-6736(14)61687-1 .
doi: 10.1016/s0140-6736(14)61687-1
pubmed: 25684585
Ellwanger B, Schüler-Toprak S, Jochem C, Leitzmann MF, Baurecht H. Anthropometric factors and the risk of ovarian cancer: a systematic review and meta-analysis. Cancer Rep (Hoboken). 2022;5(11):e1618. https://doi.org/10.1002/cnr2.1618 .
doi: 10.1002/cnr2.1618
pubmed: 35384414
Huang T, Tworoger SS, Willett WC, Stampfer MJ, Rosner BA. Associations of early life and adulthood adiposity with risk of epithelial ovarian cancer. Ann Oncol. 2019;30(2):303–9. https://doi.org/10.1093/annonc/mdy546 .
doi: 10.1093/annonc/mdy546
pubmed: 30576422
Olsen CM, Nagle CM, Whiteman DC, et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer. 2013;20(2):251–62. https://doi.org/10.1530/erc-12-0395 .
doi: 10.1530/erc-12-0395
pubmed: 23404857
Fortner RT, Rice MS, Knutsen SF, et al. Ovarian Cancer risk factor associations by primary anatomic site: the ovarian Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2020;29(10):2010–8. https://doi.org/10.1158/1055-9965.Epi-20-0354 .
doi: 10.1158/1055-9965.Epi-20-0354
pubmed: 32732252
pmcid: 7541500
Lynch J, Smith GD. A life course approach to chronic disease epidemiology. Annu Rev Public Health. 2005;26:1–35. https://doi.org/10.1146/annurev.publhealth.26.021304.144505 .
doi: 10.1146/annurev.publhealth.26.021304.144505
pubmed: 15760279
Kuh D, Ben-Shlomo Y, Lynch J, Hallqvist J, Power C. Life course epidemiology. J Epidemiol Community Health. 2003;57(10):778–83. https://doi.org/10.1136/jech.57.10.778 .
doi: 10.1136/jech.57.10.778
pubmed: 14573579
pmcid: 1732305
Koushik A, Grundy A, Abrahamowicz M, et al. Hormonal and reproductive factors and the risk of ovarian cancer. Cancer Causes Control. 2017;28(5):393–403. https://doi.org/10.1007/s10552-016-0848-9 .
doi: 10.1007/s10552-016-0848-9
pubmed: 28102526
Stunkard AJ, Sørensen T, Schulsinger F. Use of the Danish adoption Register for the study of obesity and thinness. Res Publ Assoc Res Nerv Ment Dis. 1983;60:115–20.
pubmed: 6823524
Bays HE, Bazata DD, Fox KM, Grandy S, Gavin JR 3. Perceived body image in men and women with type 2 diabetes mellitus: correlation of body mass index with the figure rating scale. Nutr J. 2009;8:57. https://doi.org/10.1186/1475-2891-8-57 .
doi: 10.1186/1475-2891-8-57
pubmed: 20003545
pmcid: 2804694
Hoyt LT, Falconi AM. Puberty and perimenopause: reproductive transitions and their implications for women’s health. Soc Sci Med. 2015;132:103–12. https://doi.org/10.1016/j.socscimed.2015.03.031 .
doi: 10.1016/j.socscimed.2015.03.031
pubmed: 25797100
pmcid: 4400253
Barbieri RL. Update in female reproduction: a life-cycle approach. J Clin Endocrinol Metab. 2008;93(7):2439–46. https://doi.org/10.1210/jc.2008-0752 .
doi: 10.1210/jc.2008-0752
pubmed: 18617698
Madathil S, Joseph L, Hardy R, Rousseau MC, Nicolau B. A bayesian approach to investigate life course hypotheses involving continuous exposures. Int J Epidemiol. 2018;47(5):1623–35. https://doi.org/10.1093/ije/dyy107 .
doi: 10.1093/ije/dyy107
pubmed: 29912384
pmcid: 6208282
Schwarz G. Estimating the dimension of a model. Ann Stat. 1978;6(2):461–4.
doi: 10.1214/aos/1176344136
Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999;28(5):964–74. https://doi.org/10.1093/ije/28.5.964 .
doi: 10.1093/ije/28.5.964
pubmed: 10597998
Gelman A, Jakulin A, Pittau MG, Su Y-S. A weakly informative default prior distribution for logistic and other regression models. Ann Appl Stat. 2008;2(4):1360–83.
doi: 10.1214/08-AOAS191
Statistics Canada. A generational portrait of Canada’s aging population from the 2021 Census. Vol. Catalogue no. 98-200-X, Issue 2021003. Statistics Canada. 2022. https://www12.statcan.gc.ca/census-recensement/2021/as-sa/98-200-X/2021003/98-200-X2021003-eng.cfm
L’Esperance K, Abrahamowicz M, O’Loughlin J, Koushik A. Childhood body fatness and the risk of epithelial ovarian cancer: a population-based case-control study in Montreal, Canada. Prev Med. 2023;178:107794. https://doi.org/10.1016/j.ypmed.2023.107794 .
doi: 10.1016/j.ypmed.2023.107794
pubmed: 38072312
Carpenter B, Gelman A, Hoffman MD, et al. Stan: a Probabilistic Programming Language. J Stat Softw. 2017;76(1):1–32. https://doi.org/10.18637/jss.v076.i01 .
doi: 10.18637/jss.v076.i01
pubmed: 36568334
pmcid: 9788645
Stan Development Team. RStan: the R inferface to Stan. 2021. https://mc-stan.org/2021
Mishra G, Nitsch D, Black S, De Stavola B, Kuh D, Hardy R. A structured approach to modelling the effects of binary exposure variables over the life course. Int J Epidemiol. 2009;38(2):528–37. https://doi.org/10.1093/ije/dyn229 .
doi: 10.1093/ije/dyn229
pubmed: 19028777
Smith AD, Hardy R, Heron J, et al. A structured approach to hypotheses involving continuous exposures over the life course. Int J Epidemiol. 2016;45(4):1271–9. https://doi.org/10.1093/ije/dyw164 .
doi: 10.1093/ije/dyw164
pubmed: 27371628
pmcid: 5841633
Premenopausal Breast Cancer Collaborative Group, Schoemaker MJ, Nichols HB, et al. Association of Body Mass Index and Age with subsequent breast Cancer Risk in Premenopausal Women. JAMA Oncol. 2018;4(11):e181771. https://doi.org/10.1001/jamaoncol.2018.1771 .
doi: 10.1001/jamaoncol.2018.1771
Fischerova D, Zikan M, Dundr P, Cibula D. Diagnosis, treatment, and follow-up of borderline ovarian tumors. Oncologist. 2012;17(12):1515–33. https://doi.org/10.1634/theoncologist.2012-0139 .
doi: 10.1634/theoncologist.2012-0139
pubmed: 23024155
pmcid: 3528384
Greer JB, Modugno F, Ness RB, Allen GO. Anthropometry and the risk of epithelial ovarian cancer. Cancer. 2006;106(10):2247–57. https://doi.org/10.1002/cncr.21830 .
doi: 10.1002/cncr.21830
pubmed: 16596653
Craig ER, Londoño AI, Norian LA, Arend RC. Metabolic risk factors and mechanisms of disease in epithelial ovarian cancer: a review. Gynecol Oncol. 2016;143(3):674–83. https://doi.org/10.1016/j.ygyno.2016.10.005 .
doi: 10.1016/j.ygyno.2016.10.005
pubmed: 27751590
pmcid: 5689410
Lukanova A, Kaaks R. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev. 2005;14(1):98–107.
doi: 10.1158/1055-9965.98.14.1
pubmed: 15668482
Fernihough A, McGovern ME. Physical stature decline and the health status of the elderly population in England. Econ Hum Biol. 2015;16:30–44. https://doi.org/10.1016/j.ehb.2013.12.010 .
doi: 10.1016/j.ehb.2013.12.010
pubmed: 24508050
Connor Gorber S, Tremblay M, Moher D, Gorber B. A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev. 2007;8(4):307–26. https://doi.org/10.1111/j.1467-789X.2007.00347.x .
doi: 10.1111/j.1467-789X.2007.00347.x
pubmed: 17578381
Krul AJ, Daanen HA, Choi H. Self-reported and measured weight, height and body mass index (BMI) in Italy, the Netherlands and North America. Eur J Public Health. 2011;21(4):414–9. https://doi.org/10.1093/eurpub/ckp228 .
doi: 10.1093/eurpub/ckp228
pubmed: 20089678
Craig BM, Adams AK. Accuracy of body mass index categories based on self-reported height and weight among women in the United States. Matern Child Health J. 2009;13(4):489–96. https://doi.org/10.1007/s10995-008-0384-7 .
doi: 10.1007/s10995-008-0384-7
pubmed: 18607705
Must A, Willett WC, Dietz WH. Remote recall of childhood height, weight, and body build by elderly subjects. Am J Epidemiol. 1993;138(1):56–64. https://doi.org/10.1093/oxfordjournals.aje.a116777 .
doi: 10.1093/oxfordjournals.aje.a116777
pubmed: 8333427
Lebel A, Subramanian SV, Hamel D, Gagnon P, Razak F. Population-level trends in the distribution of body mass index in Canada, 2000–2014. Can J Public Health. 2018;109(4):539–48. https://doi.org/10.17269/s41997-018-0060-7 .
doi: 10.17269/s41997-018-0060-7
pubmed: 29981102
pmcid: 6964638
Dutton DJ, McLaren L. Explained and unexplained regional variation in Canadian obesity prevalence. Obes (Silver Spring). 2011;19(7):1460–8. https://doi.org/10.1038/oby.2010.339 .
doi: 10.1038/oby.2010.339
Statistics Canada. Tables 13-10-0554-01: Body mass index (BMI), by age group and sex, household population aged 18 and over excluding pregnant women, Canada, provinces, territories, health regions (January 2000 boundaries) and peer groups. 2017. https://doi.org/10.25318/1310055401-eng
Statistics Canada. Tables 13-10-0805-01: Health characteristics, two-year period estimates, census metropolitan areas and population centres. 2022. https://doi.org/10.25318/1310080501-eng
Miller ER, Wilson C, Chapman J, et al. Connecting the dots between breast cancer, obesity and alcohol consumption in middle-aged women: ecological and case control studies. BMC Public Health. 2018;18(1):460. https://doi.org/10.1186/s12889-018-5357-1 .
doi: 10.1186/s12889-018-5357-1
pubmed: 29625601
pmcid: 5889566
Zhu K, McKnight B, Stergachis A, Daling JR, Levine RS. Comparison of self-report data and medical records data: results from a case-control study on prostate cancer. Int J Epidemiol. 1999;28(3):409–17. https://doi.org/10.1093/ije/28.3.409 .
doi: 10.1093/ije/28.3.409
pubmed: 10405842
Canoy D, Wareham N, Luben R, et al. Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obes Res. 2005;13(8):1466–75. https://doi.org/10.1038/oby.2005.177 .
doi: 10.1038/oby.2005.177
pubmed: 16129730
Hernán MA, Hernández-Díaz S, Robins JM. A structural approach to selection bias. Epidemiol. 2004;15(5):615–25. https://doi.org/10.1097/01.ede.0000135174.63482.43 .
doi: 10.1097/01.ede.0000135174.63482.43